Resolving gastric cancer aetiology: an update in genetic predisposition

Van Cutsem, 2016, Gastric cancer, Lancet, 388, 2654, 10.1016/S0140-6736(16)30354-3 Karimi, 2014, Gastric cancer: descriptive epidemiology, risk factors, screening, and prevention, Cancer Epidemiol Biomarkers Prev, 23, 700, 10.1158/1055-9965.EPI-13-1057 Ferlay, 2015, Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012, Int J Cancer, 136, E359, 10.1002/ijc.29210 Siewert, 1996, Carcinoma of the gastroesophageal junction-classification, pathology and extent of resection, Dis Esophagus, 9, 173 Colquhoun, 2015, Global patterns of cardia and non-cardia gastric cancer incidence in 2012, Gut, 64, 1881, 10.1136/gutjnl-2014-308915 Liu, 2017, Gastric cancer in the era of precision medicine, Cell Mol Gastroenterol Hepatol, 3, 348, 10.1016/j.jcmgh.2017.02.003 Ma, 2016, Lauren classification and individualized chemotherapy in gastric cancer, Oncol Lett, 11, 2959, 10.3892/ol.2016.4337 Plummer, 2015, Global burden of gastric cancer attributable to Helicobacter pylori, Int J Cancer, 136, 487, 10.1002/ijc.28999 Khan, 2014, Global burden of deaths from Epstein-Barr virus attributable malignancies 1990–2010, Infect Agent Cancer, 9, 38, 10.1186/1750-9378-9-38 Siegel, 2015, Cancer statistics for Hispanics/Latinos, 2015, CA Cancer J Clin, 65, 457, 10.3322/caac.21314 Wu, 2009, Stomach carcinoma incidence patterns in the United States by histologic type and anatomic site, Cancer Epidemiol Biomarkers Prev, 18, 1945, 10.1158/1055-9965.EPI-09-0250 Devessa, 1998, Changing patterns in the incidence of esophageal and gastric carcinoma in the United States, Cancer, 83, 2049, 10.1002/(SICI)1097-0142(19981115)83:10<2049::AID-CNCR1>3.0.CO;2-2 Chen, 2013, Body mass index and risk of gastric cancer: a meta-analysis of a population with more than ten million from 24 prospective studies, Cancer Epidemiol Biomarkers Prev, 22, 1395, 10.1158/1055-9965.EPI-13-0042 Figueroa, 2009, Cigarette smoking, body mass index, gastro-esophageal reflux disease, and non-steroidal anti-inflammatory drug use and risk of subtypes of esophageal and gastric cancers by P53 overexpression, Cancer Causes Control, 20, 361, 10.1007/s10552-008-9250-6 Engel, 2003, Population attributable risks of esophageal and gastric cancers, J Natl Cancer Inst, 95, 1404, 10.1093/jnci/djg047 Anderson, 2018, The changing face of noncardia gastric cancer incidence among US non-Hispanic whites, J Natl Cancer Inst, 110, 608, 10.1093/jnci/djx262 Gonzalez, 2003, Smoking and the risk of gastric cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC), Int J Cancer, 107, 629, 10.1002/ijc.11426 Bagnardi, 2015, Alcohol consumption and site-specific cancer risk: a comprehensive dose-response meta-analysis, Br J Cancer, 112, 580, 10.1038/bjc.2014.579 Sjodahl, 2007, Smoking and alcohol drinking in relation to risk of gastric cancer: a population-based, prospective cohort study, Int J Cancer, 120, 128, 10.1002/ijc.22157 Fitzgerald, 2010, Hereditary diffuse gastric cancer: updated consensus guidelines for clinical management and directions for future research, J Med Genet, 47, 436, 10.1136/jmg.2009.074237 Lichtenstein, 2000, Environmental and heritable factors in the causation of cancer—analyses of cohorts of twins from Sweden, Denmark, and Finland, N Engl J Med, 343, 78, 10.1056/NEJM200007133430201 Guilford, 1998, E-cadherin germline mutations in familial gastric cancer, Nature, 392, 402, 10.1038/32918 Abnet, 2010, A shared susceptibility locus in PLCE1 at 10q23 for gastric adenocarcinoma and esophageal squamous cell carcinoma, Nat Genet, 42, 764, 10.1038/ng.649 Helgason, 2015, Loss-of-function variants in ATM confer risk of gastric cancer, Nat Genet, 47, 906, 10.1038/ng.3342 Huang, 2018, Pathogenic germline variants in 10,389 adult cancers, Cell, 173, 355, 10.1016/j.cell.2018.03.039 Jin, 2012, Genetic variants at 6p21.1 and 7p15.3 are associated with risk of multiple cancers in Han Chinese, Am J Hum Genet, 91, 928, 10.1016/j.ajhg.2012.09.009 Saeki, 2011, A functional single nucleotide polymorphism in mucin 1, at chromosome 1q22, determines susceptibility to diffuse-type gastric cancer, Gastroenterology, 140, 892, 10.1053/j.gastro.2010.10.058 Sahasrabudhe, 2017, Germline mutations in PALB2, BRCA1, and RAD51C, which regulate DNA recombination repair, in patients with gastric cancer, Gastroenterology, 152, 983, 10.1053/j.gastro.2016.12.010 Sakamoto, 2008, Genetic variation in PSCA is associated with susceptibility to diffuse-type gastric cancer, Nat Genet, 40, 730, 10.1038/ng.152 Shi, 2011, A genome-wide association study identifies new susceptibility loci for non-cardia gastric cancer at 3q13.31 and 5p13.1, Nat Genet, 43, 1215, 10.1038/ng.978 Slavin, 2017, Genetic gastric cancer susceptibility in the International Clinical Cancer Genomics Community Research Network, Cancer Genet, 216–17, 111, 10.1016/j.cancergen.2017.08.001 Wang, 2017, Identification of new susceptibility loci for gastric non-cardia adenocarcinoma: pooled results from two Chinese genome-wide association studies, Gut, 66, 581, 10.1136/gutjnl-2015-310612 Mendonsa, 2018, E-cadherin in contact inhibition and cancer, Oncogene, 37, 4769, 10.1038/s41388-018-0304-2 van der Post, 2015, Hereditary diffuse gastric cancer: updated clinical guidelines with an emphasis on germline CDH1 mutation carriers, J Med Genet, 52, 361, 10.1136/jmedgenet-2015-103094 Colvin, 2015, Hereditary gastric cancer syndromes, Surg Oncol Clin N Am, 24, 765, 10.1016/j.soc.2015.06.002 Hansford, 2015, Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond, JAMA Oncol, 1, 23, 10.1001/jamaoncol.2014.168 Mi, 2018, Comparative study of endoscopic surveillance in hereditary diffuse gastric cancer according to CDH1 mutation status, Gastrointest Endosc, 87, 408, 10.1016/j.gie.2017.06.028 Lim, 2014, Prospective cohort study assessing outcomes of patients from families fulfilling criteria for hereditary diffuse gastric cancer undergoing endoscopic surveillance, Gastrointest Endosc, 80, 78, 10.1016/j.gie.2013.11.040 Hebbard, 2009, Prophylactic total gastrectomy (PTG) for hereditary diffuse gastric cancer (HDGC): the Newfoundland experience with 23 patients, Ann Surg Oncol, 16, 1890, 10.1245/s10434-009-0471-z Majewski, 2013, An alpha-E-catenin (CTNNA1) mutation in hereditary diffuse gastric cancer, J Pathol, 229, 621, 10.1002/path.4152 van der Post, 2017, Emerging concepts in gastric neoplasia: heritable gastric cancers and polyposis disorders, Surg Pathol Clin, 10, 931, 10.1016/j.path.2017.07.011 van der Post, 2015, Accuracy of hereditary diffuse gastric cancer testing criteria and outcomes in patients with a germline mutation in CDH1, Gastroenterology, 149, 897, 10.1053/j.gastro.2015.06.003 Fewings, 2018, Germline pathogenic variants in PALB2 and other cancer-predisposing genes in families with hereditary diffuse gastric cancer without CDH1 mutation: a whole-exome sequencing study, Lancet Gastroenterol Hepatol, 3, 489, 10.1016/S2468-1253(18)30079-7 Lu, 2015, Patterns and functional implications of rare germline variants across 12 cancer types, Nat Commun, 6, 10086, 10.1038/ncomms10086 Li, 2016, Point mutations in exon 1B of APC reveal gastric adenocarcinoma and proximal polyposis of the stomach as a familial adenomatous polyposis variant, Am J Human Genet, 98, 830, 10.1016/j.ajhg.2016.03.001 Repak, 2016, The first European family with gastric adenocarcinoma and proximal polyposis of the stomach: case report and review of the literature, Gastrointest Endosc, 84, 718, 10.1016/j.gie.2016.06.023 Worthley, 2012, Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome, Gut, 61, 774, 10.1136/gutjnl-2011-300348 Yanaru-Fujisawa, 2012, Familial fundic gland polyposis with gastric cancer, Gut, 61, 1103, 10.1136/gutjnl-2011-301384 Oliveira, 2009, Hereditary gastric cancer, Best Pract Res Clin Gastroenterol, 23, 147, 10.1016/j.bpg.2009.02.003 Caldas, 1999, Familial gastric cancer: overview and guidelines for management, J Med Genet, 36, 873 Kluijt, 2012, Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance, Fam Cancer, 11, 363, 10.1007/s10689-012-9521-y Chen, 2006, Prediction of germline mutations and cancer risk in the Lynch syndrome, JAMA, 296, 1479, 10.1001/jama.296.12.1479 Hampel, 2005, Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer), N Engl J Med, 352, 1851, 10.1056/NEJMoa043146 Watson, 2008, The risk of extra-colonic, extra-endometrial cancer in the Lynch syndrome, Int J Cancer, 123, 444, 10.1002/ijc.23508 Vasen, 2013, Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts, Gut, 62, 812, 10.1136/gutjnl-2012-304356 Barrow, 2009, Cumulative lifetime incidence of extracolonic cancers in Lynch syndrome: a report of 121 families with proven mutations, Clin Genet, 75, 141, 10.1111/j.1399-0004.2008.01125.x Therkildsen, 2017, Towards gene- and gender-based risk estimates in Lynch syndrome; age-specific incidences for 13 extra-colorectal cancer types, Br J Cancer, 117, 1702, 10.1038/bjc.2017.348 Moreira, 2016, Surveillance of patients with hereditary gastrointestinal cancer syndromes, Best Pract Res Clin Gastroenterol, 30, 923, 10.1016/j.bpg.2016.10.004 Syngal, 2015, ACG clinical guideline: Genetic testing and management of hereditary gastrointestinal cancer syndromes, Am J Gastroenterol, 110, 223, 10.1038/ajg.2014.435 Kopacova, 2009, Peutz-Jeghers syndrome: diagnostic and therapeutic approach, World J Gastroenterol, 15, 5397, 10.3748/wjg.15.5397 van Lier, 2010, High cancer risk in Peutz-Jeghers syndrome: a systematic review and surveillance recommendations, Am J Gastroenterol, 105, 1258, 10.1038/ajg.2009.725 Jagelman, 1988, Upper gastrointestinal cancer in familial adenomatous polyposis, Lancet, 331, 1149, 10.1016/S0140-6736(88)91962-9 Masciari, 2011, Gastric cancer in individuals with Li-Fraumeni syndrome, Genet Med, 13, 651, 10.1097/GIM.0b013e31821628b6 Rebbeck, 2018, Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations, Hum Mutat, 39, 593, 10.1002/humu.23406 Friedenson, 2005, BRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarian, MedGenMed, 7, 60 Antoniou, 2014, Breast-cancer risk in families with mutations in PALB2, N Engl J Med, 371, 497, 10.1056/NEJMoa1400382 Jones, 2009, Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene, Science, 324, 217, 10.1126/science.1171202 Prakash, 2015, Homologous recombination and human health: the roles of BRCA1, BRCA2, and associated proteins, Cold Spring Harb Perspect Biol, 7, a016600, 10.1101/cshperspect.a016600 Lord, 2016, BRCAness revisited, Nat Rev Cancer, 16, 110, 10.1038/nrc.2015.21 Carvajal-Carmona, 2018, PALB2 as a familial gastric cancer gene: is the wait over?, Lancet Gastroenterol Hepatol, 3, 451, 10.1016/S2468-1253(18)30120-1 Hu, 2016, Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumours, Gut, 65, 1611, 10.1136/gutjnl-2015-309340 2014, Comprehensive molecular characterization of gastric adenocarcinoma, Nature, 513, 202, 10.1038/nature13480 Ng, 2008, Genetic regulation of MUC1 alternative splicing in human tissues, Br J Cancer, 99, 978, 10.1038/sj.bjc.6604617 Nath, 2014, MUC1: a multifaceted oncoprotein with a key role in cancer progression, Trends Mol Med, 20, 332, 10.1016/j.molmed.2014.02.007 McGuckin, 2007, Muc1 mucin limits both Helicobacter pylori colonization of the murine gastric mucosa and associated gastritis, Gastroenterology, 133, 1210, 10.1053/j.gastro.2007.07.003 Horm, 2013, MUC1 and metastatic cancer: expression, function and therapeutic targeting, Cell Adh Migr, 7, 187, 10.4161/cam.23131 Wang, 2011, Zinc finger protein ZBTB20 expression is increased in hepatocellular carcinoma and associated with poor prognosis, BMC Cancer, 11, 271, 10.1186/1471-2407-11-271 Hardie, 2008, AMPK: a key regulator of energy balance in the single cell and the whole organism, Int J Obes (Lond), 32, S7, 10.1038/ijo.2008.116 Ross, 2016, AMP-activated protein kinase: a cellular energy sensor that comes in 12 flavours, FEBS J, 283, 2987, 10.1111/febs.13698 Gupta, 2010, Inhibiting NF-κB activation by small molecules as a therapeutic strategy, Biochim Biophys Acta, 1799, 775, 10.1016/j.bbagrm.2010.05.004 Heinz, 2012, The death domain-containing protein Unc5L is a novel MyD88-independent activator of the pro-inflammatory IRAK signaling cascade, Cell Death Differ, 19, 722, 10.1038/cdd.2011.147 Saeki, 2015, rs2294008T, a risk allele for gastric and gallbladder cancers, surpresses the PSCA promoter by recruiting the transcription factor YY1, Genes Cells, 20, 382, 10.1111/gtc.12228 Zhang, 2016, PSCA acts as a tumor suppressor by facilitating the nuclear translocation of RB1CC1 in esophageal squamous cell carcinoma, Carcinogenesis, 37, 320, 10.1093/carcin/bgw010 Tyutyunnykova, 2017, The controversial role of phospholipase C epsilon (PLCɛ) in cancer development and progression, J Cancer, 8, 716, 10.7150/jca.17779 Zhu, 2010, Gastric carcinoma in China: current status and future perspectives (review), Oncol Lett, 1, 407, 10.3892/ol_00000071 Criollo-Rayo, 2018, Native American gene continuity to the modern admixed population from the Colombian Andes: implication for biomedical, population and forensic studies, Forensic Sci Int Genet, 36, e1, 10.1016/j.fsigen.2018.06.006 Alexandrov, 2015, A mutational signature in gastric cancer suggests therapeutic strategies, Nat Commun, 6, 676, 10.1038/ncomms9683 Bang, 2017, Olaparib in combination with paclitaxel in patients with advanced gastric cancer who have progressed following first-line therapy (GOLD): a double-blind, randomised, placebo-controlled, phase 3 trial, Lancet Oncol, 18, 1637, 10.1016/S1470-2045(17)30682-4